Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 9/20 | 0.45 |
| ▸ | CA9 | Q16790 | 9/20 | 0.45 |
| ▸ | CA1 | P00915 | 8/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | STS | P08842 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12490776 | 0.82 | ALDH1A1 (0.62) | CA2CA9CA1ALDH1A1STS | |
| SCHEMBL731975 | 0.81 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2ALMNAMAPK1 | |
| SCHEMBL7787737 | 0.81 | SMN1; SMN2 (0.44) | ALDH1A1MEN1KMT2ALMNAMAPK1 | |
| SCHEMBL29743115 | 0.81 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2ALMNAMAPK1 | |
| SCHEMBL28986963 | 0.79 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2ALMNAMAPK1 | |
| SCHEMBL9451267 | 0.79 | CA2 (0.61) | CA2CA9CA1STS | |
| SCHEMBL9236086 | 0.78 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2ALMNAMAPK1 | |
| SCHEMBL7086093 | 0.77 | ALDH1A1 (0.44) | ALDH1A1MEN1KMT2ALMNAMAPK1 | |
| SCHEMBL7107507 | 0.77 | ALDH1A1 (0.40) | ALDH1A1MEN1KMT2ALMNAMAPK1 | |
| SCHEMBL8813181 | 0.77 | ALDH1A1 (0.44) | CA2CA9CA1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2686298-B1 | SUBSTITUTED DIPHENYL DERIVATIVES | CREATIVE THERAPEUTICS GMBH (DE) | 2018-05-09 | — | — | EP | disclosed |